Final-Program-ATS-2023-AP.vp

332

WEDNESDAY • MAY 24

Chairing: D.C. Patel, DO, MBA, Gainesville, FL O.N. Obi, MD, MPH, MSc, Greenville, NC 12:00 My Experience with Getting a Diagnosis and Treatment for Sarcoidosis Speaker To Be Announced 12:08 The State of Sarcoidosis Care D.C. Patel, DO, MBA, Gainesville, FL 12:12 The “Primary Sarcoidosis Specialist” P.H.S. Sporn, MD, ATSF, FCCP, Chicago, IL 12:22 The Burden of Sarcoidosis on Patients L. Harper, MD, MSCR, Cleveland, OH 12:31 Non-Organ Related Manifestations of Sarcoidosis V. Kahlmann, MD, Rotterdam, Netherlands 12:41 Social Determinants and How They Impact Sarcoidosis Care Y. Cozier, DSc, MPH, Boston, MA 12:50 Measuring Outcomes to Improve Care in Sarcoidosis M. Sharp, MD, MHS, Baltimore, MD 1:00 Discussions C. Bonham, MD, Charlottesville, VA FROM GENES TO CLINICAL TRIALS: STATE-OF-THE-ART APPROACHES TO HETEROGENEITY IN THE ICU Assemblies on Critical Care; Clinical Problems; Respiratory Structure and Function 12:00 PM - 1:30 PM Marriott Marquis Washington Independence Ballroom Salons A-D (Level M4) Target Audience Clinicians (RN, NP, MD) who care for critically ill patients and researches who wish to improve the rigor with which they understand clinical trial data. Objectives At the conclusion of this session, the participant will be able to: • describe novel approaches to phenotyping in acute critical care syndromes • describe new findings concerning the complexity of critical care syndromes • define new strategies to manage the care of ARDS and septic shock Heterogeneity is increasingly recognized as a central challenge in critical care research. Sub-phenotyping and endotyping efforts designed BASIC • CLINICAL • TRANSLATIONAL CRITICAL CARE TRACK CME Credits Available: 1.5 D84

12:36 Epidemiologic Evidence for Metformin in COPD T.D. Wu, MD, MHS, Houston, TX 12:45 Antiplatelet Therapy in COPD A. Fawzy, MD, MPH, Baltimore, MD 12:54 Clinical Trial Considerations F.J. Martinez, MD, MS, New York, NY 1:03 Panel Discussion 1:26 Concluding Remarks I.M. Adcock, PhD, London, United Kingdom This session and the International Conference are supported by an independent medical educational grant from AstraZeneca LP. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests). ESTABLISHING A PARADIGM FOR MULTIDISCIPLINARY CARE IN SARCOIDOSIS Assemblies on Clinical Problems; Environmental, Occupational and Population Health 12:00 PM - 1:30 PM Walter E. Washington Convention Center Room 145 A-B (Street Level) Target Audience Healthcare providers and trainees from across disciplines that care for patients with sarcoidosis or other chronic/systemic conditions. Objectives At the conclusion of this session, the participant will be able to: • understand our current systems of practice, how they limit access and the specific concerns patient with sarcoidosis have • learn about ways to improve multidisciplinary care and access to care • discuss ways to improve our structure/practices/systems to reduce disparities Sarcoidosis is an inflammatory multi-organ disease with a wide variety of clinical manifestations that requires a team approach to address the needs of patients. Oftentimes patients lack the resources to navigate the complex health care systems. The challenges are exacerbated by the fact that sarcoidosis disproportionately impacts Black patients and these patients are also impacted by entrenched institutional biases in medicine. This session will propose to improve our current models of care to meet the needs of the patients, and will propose the concept of “primary sarcoidosis specialist” as an alternative to current models of care. CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 1.5 D83

ATS 2023 • Washington, DC